Matthew Booty - Publications

Affiliations: 
2008- Harvard University, Cambridge, MA, United States 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Booty MG, Hlavaty KA, Stockmann A, Ozay EI, Smith C, Tian L, How E, Subramanya D, Venkitaraman A, Yee C, Pryor O, Volk K, Blagovic K, Vicente-Suarez I, Yarar D, et al. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8 T Cell Responses with Antitumor Activity. Journal of Immunology (Baltimore, Md. : 1950). PMID 35091434 DOI: 10.4049/jimmunol.2100656  0.468
2020 Ozay E, Booty M, Blagovic K, Soto D, Pryor O, Stockmann A, Subramanya D, Volk K, Sharei A, Bernstein H, Yarar D, Seidl K, Loughhead S. 170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming Journal For Immunotherapy of Cancer. 8: A184-A184. DOI: 10.1136/jitc-2020-sitc2020.0170  0.44
2020 Booty M, Stockmann A, Pryor O, Myint M, Trumpfheller C, Nicolini V, Klein C, Codarri L, Umana P, Sharei A, Bernstein H, Seidl K, Loughhead S. 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants Journal For Immunotherapy of Cancer. 8: A155-A155. DOI: 10.1136/jitc-2020-sitc2020.0141  0.307
2019 Hlavaty KA, Booty MG, Loughhead S, Blagovic K, Vicente-Suarez A, Yarar D, Bernstein H, Sharei A. Abstract 3187: Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform Cancer Research. 79: 3187-3187. DOI: 10.1158/1538-7445.Am2019-3187  0.422
2017 Mishra BB, Lovewell RR, Olive AJ, Zhang G, Wang W, Eugenin E, Smith CM, Phuah JY, Long JE, Dubuke ML, Palace SG, Goguen JD, Baker RE, Nambi S, Mishra R, ... Booty MG, et al. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nature Microbiology. 2: 17072. PMID 28504669 DOI: 10.1038/Nmicrobiol.2017.72  0.348
2016 Booty MG, Barreira-Silva P, Carpenter SM, Nunes-Alves C, Jacques MK, Stowell BL, Jayaraman P, Beamer G, Behar SM. IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection. Scientific Reports. 6: 36720. PMID 27819295 DOI: 10.1038/Srep36720  0.72
2016 Marakalala MJ, Raju RM, Sharma K, Zhang YJ, Eugenin EA, Prideaux B, Daudelin IB, Chen PY, Booty MG, Kim JH, Eum SY, Via LE, Behar SM, Barry CE, Mann M, et al. Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nature Medicine. PMID 27043495 DOI: 10.1038/Nm.4073  0.573
2016 Booty MG, Nunes-Alves C, Carpenter SM, Jayaraman P, Behar SM. Multiple Inflammatory Cytokines Converge To Regulate CD8+ T Cell Expansion and Function during Tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). 196: 1822-31. PMID 26755819 DOI: 10.4049/Jimmunol.1502206  0.742
2016 Carpenter SM, Nunes-Alves C, Booty MG, Way SS, Behar SM. A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during Tuberculosis. Plos Pathogens. 12: e1005380. PMID 26745507 DOI: 10.1371/Journal.Ppat.1005380  0.756
2016 Carpenter SM, Nunes-Alves C, Booty MG, Way SS, Behar SM. A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during Tuberculosis Plos Pathogens. 12. DOI: 10.1371/journal.ppat.1005380  0.724
2015 Nunes-Alves C, Booty MG, Carpenter SM, Rothchild AC, Martin CJ, Desjardins D, Steblenko K, Kløverpris HN, Madansein R, Ramsuran D, Leslie A, Correia-Neves M, Behar SM. Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection. Plos Pathogens. 11: e1004849. PMID 25945999 DOI: 10.1371/Journal.Ppat.1004849  0.706
2014 Behar SM, Carpenter SM, Booty MG, Barber DL, Jayaraman P. Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus. Seminars in Immunology. 26: 559-77. PMID 25311810 DOI: 10.1016/J.Smim.2014.09.003  0.725
2014 Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM. In search of a new paradigm for protective immunity to TB. Nature Reviews. Microbiology. 12: 289-99. PMID 24590243 DOI: 10.1038/Nrmicro3230  0.689
2012 Martin CJ, Booty MG, Rosebrock TR, Nunes-Alves C, Desjardins DM, Keren I, Fortune SM, Remold HG, Behar SM. Efferocytosis is an innate antibacterial mechanism. Cell Host & Microbe. 12: 289-300. PMID 22980326 DOI: 10.1016/J.Chom.2012.06.010  0.712
2011 Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunology. 4: 279-87. PMID 21307848 DOI: 10.1038/mi.2011.3  0.647
Show low-probability matches.